209 related articles for article (PubMed ID: 15936820)
1. Mechanisms of nociception evoked by intrathecal high-dose morphine.
Sakurada T; Komatsu T; Sakurada S
Neurotoxicology; 2005 Oct; 26(5):801-9. PubMed ID: 15936820
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice.
Komatsu T; Sakurada S; Katsuyama S; Sanai K; Sakurada T
Int Rev Neurobiol; 2009; 85():207-19. PubMed ID: 19607972
[TBL] [Abstract][Full Text] [Related]
3. [Study of Supplementary Analgesics Capable of Reducing the Dosage of Morphine].
Komatsu T
Yakugaku Zasshi; 2016; 136(2):329-35. PubMed ID: 26831810
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal substance P (1-7) prevents morphine-evoked spontaneous pain behavior via spinal NMDA-NO cascade.
Sakurada T; Komatsu T; Kuwahata H; Watanabe C; Orito T; Sakurada C; Tsuzuki M; Sakurada S
Biochem Pharmacol; 2007 Sep; 74(5):758-67. PubMed ID: 17658485
[TBL] [Abstract][Full Text] [Related]
5. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
DeLander GE; Wahl JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
[TBL] [Abstract][Full Text] [Related]
6. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
7. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
[TBL] [Abstract][Full Text] [Related]
8. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
Björkman R
Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
[TBL] [Abstract][Full Text] [Related]
9. Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide.
Komatsu T; Sakurada S; Kohno K; Shiohira H; Katsuyama S; Sakurada C; Tsuzuki M; Sakurada T
Biochem Pharmacol; 2009 Oct; 78(8):1026-34. PubMed ID: 19589334
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments.
Komatsu T; Sasaki M; Sanai K; Kuwahata H; Sakurada C; Tsuzuki M; Iwata Y; Sakurada S; Sakurada T
Peptides; 2009 Sep; 30(9):1689-96. PubMed ID: 19520130
[TBL] [Abstract][Full Text] [Related]
11. [Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord].
Sun XC; Li WB; Li SQ; Li QJ; Chen XL; Ai J
Sheng Li Xue Bao; 2003 Dec; 55(6):677-83. PubMed ID: 14695485
[TBL] [Abstract][Full Text] [Related]
12. Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: a behavioural and microdialysis study in rats.
Watanabe C; Okuda K; Sakurada C; Ando R; Sakurada T; Sakurada S
Brain Res; 2003 Nov; 990(1-2):77-86. PubMed ID: 14568332
[TBL] [Abstract][Full Text] [Related]
13. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
[TBL] [Abstract][Full Text] [Related]
15. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
16. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
[TBL] [Abstract][Full Text] [Related]
17. Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22.
Chen T; Hu Z; Quirion R; Hong Y
Neuropharmacology; 2008 Apr; 54(5):796-803. PubMed ID: 18249418
[TBL] [Abstract][Full Text] [Related]
18. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine.
Yaksh TL; Harty GJ
J Pharmacol Exp Ther; 1988 Feb; 244(2):501-7. PubMed ID: 3346833
[TBL] [Abstract][Full Text] [Related]
20. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
